ARCHIVES

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

This article is from The Cancer Letter archive.

Vol. 40 No. 22 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

NCI-Approved Clinical Trials

November 26, 2004

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

Other DCT Concepts Approved By BSC

June 6, 1986

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993